22157.jpg
Chemotherapy Induced Peripheral Neuropathy Drug Pipeline Research 2024: Therapeutics Assessment by Product Type, Stage, Route of Administration, and Molecule Type
26 juin 2024 09h26 HE | Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.An insightful report...
22157.jpg
Chemotherapy Induced Nausea and Vomiting Drug Pipeline Research 2024 Featuring Helsinn Healthcare, Acacia Pharma, Camurus, Benuvia Therapeutics, Aphios, and Zhuhai Beihai Biotech
24 juin 2024 09h47 HE | Research and Markets
Dublin, June 24, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Nausea and Vomiting - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report...
logo.jpg
Helsinn Group announces AKYNZEO® (fosnetupitant/palonosetron) injection is now available in a ready-to-use vial in the US
24 juin 2024 08h00 HE | Helsinn Healthcare S.A.
Helsinn Group announces AKYNZEO® (fosnetupitant/palonosetron) injection is now available in a ready-to-use vial in the US Lugano, Switzerland – June 24, 2024 – Helsinn Group (“Helsinn”), a global...
22157.jpg
Chemotherapy-Induced Pain Markets: Epidemiology, Trends, and Forecasts (2024-2034) Across the 7 Major Markets
12 juin 2024 09h45 HE | Research and Markets
Dublin, June 12, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy-Induced Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...
22157.jpg
Chemotherapy-Induced Anemia Pipeline Insights Report, 2024 Featuring Analysis of Roxadustat (FibroGen), SPP-003 (SBI Pharmaceuticals), and More
31 mai 2024 06h26 HE | Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy-Induced Anemia - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
cmi_logo.png
[Latest] Global Colorectal Cancer Market Size/Share Worth USD 30,095.9 Million by 2033 at a 3.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
20 mai 2024 12h30 HE | Custom Market Insights
Austin, TX, USA, May 20, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Colorectal Cancer Market Size, Trends and Insights By Type of Treatment (Surgery,...
BCC Identity-01.png
Brain Cancer Canada awards The Dwayne Andrews Glioblastoma Grant for Research to a study on the impact of anesthetics on brain cancer proliferation
08 mai 2024 08h45 HE | Brain Cancer Canada
Brain Cancer Canada grants $80k to study impact of anesthetics on brain tumor growth, led by Dr. Sujoy Banik.
cmi_logo.png
[Latest] Global Breast Cancer Therapeutics Market Size/Share Worth USD 66.1 Billion by 2033 at a 6.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
06 mai 2024 08h30 HE | Custom Market Insights
Austin, TX, USA, May 06, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Breast Cancer Therapeutics Market Size, Trends and Insights By Type of Therapy...
22157.jpg
APAC Chemotherapy-Induced Peripheral Neuropathy (CIPN) Patient Pool Analysis, Market Size and Market Forecast Report 2024-2034
30 avr. 2024 07h44 HE | Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy-Induced Peripheral Neuropathy (CIPN) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034" report has been added to ...
IMG_5056
Derm-Biome Pharmaceuticals’ topical therapy shows positive results in preclinical skin cancer trial: drug prevents the development of precancerous skin conditions and treats existing skin cancers with no observable side effects. 
17 avr. 2024 10h15 HE | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- The rates of precancerous skin conditions and skin cancers are soaring in many parts of the world. Actinic keratosis (AK) is the most...